title: Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.
abstract: Bronchiolitis obliterans organizing pneumonia (BOOP) and acute respiratory distress syndrome (ARDS) are two clinically and histologically distinct syndromes sharing the presence of an inflammatory and fibrotic component. Apoptosis via the Fas/Fas ligand (FasL) pathway plays an important role in the development of acute lung injury and fibrosis characteristic of these and other pulmonary inflammatory and fibrotic syndromes. We evaluated the role of apoptosis via the Fas/FasL pathway in the development of pulmonary inflammation and fibrosis in reovirus 1/L-induced BOOP and ARDS. CBA/J mice were intranasally inoculated with saline, 1 x 10(6) (BOOP), or 1 x 10(7) (ARDS) PFU reovirus 1/L, and evaluated at various days postinoculation for in situ apoptosis by TUNEL analysis and Fas/FasL expression. Our results demonstrate the presence of apoptotic cells and up-regulation of Fas/FasL expression in alveolar epithelium and in infiltrating cells during the inflammatory and fibrotic stages of both reovirus 1/L-induced ARDS and BOOP. Treatment of mice with the caspase 8 inhibitor, zIETD-fmk, inhibited apoptosis, inflammation, and fibrotic lesion development in reovirus 1/L-induced BOOP and ARDS. However, CBA/KlJms-Fas(lpr-cg)/J mice, which carry a point mutation in the Fas cytoplasmic region that abolishes the ability of Fas to transduce an apoptotic signal, do not develop pulmonary inflammation and fibrotic lesions associated with reovirus 1/L-induced BOOP, but still develop inflammation and fibrotic lesions associated with reovirus 1/L-induced ARDS. These results suggest a differential role for the Fas/FasL apoptotic pathway in the development of inflammation and fibrotic lesions associated with BOOP and ARDS.
authors.affiliation: Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Andrea D
authors.initials: AD
authors.lastname: Lopez
authors.forename: Sreedevi
authors.initials: S
authors.lastname: Avasarala
authors.forename: Suman
authors.initials: S
authors.lastname: Grewal
authors.forename: Anuradha K
authors.initials: AK
authors.lastname: Murali
authors.forename: Lucille
authors.initials: L
authors.lastname: London
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000276:immunology*; D018549:Cryptogenic Organizing Pneumonia / Q000276:immunology* / Q000473:pathology / Q000821:virology; D053222:Fas Ligand Protein / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D005260:Female; D018836:Inflammation Mediators / Q000502:physiology*; D051379:Mice; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D030102:Orthoreovirus, Mammalian / Q000276:immunology*; D011658:Pulmonary Fibrosis / Q000276:immunology* / Q000473:pathology; D012128:Respiratory Distress Syndrome / Q000276:immunology* / Q000473:pathology / Q000821:virology; D015398:Signal Transduction / Q000276:immunology*; D019014:fas Receptor / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*
chemical_list: D053222:Fas Ligand Protein; D018836:Inflammation Mediators; D019014:fas Receptor